Merck is the name of a German familyfamily family, on which the establishment of the two firms of world-wide reputation Merck KGaA from each other independent since the First World War in Darmstadt and Merck & Co., Inc. in Whitehouse station to lead back new jersey (the USA) is. Latter enterprise possesses only the rights of the use of a name for North America and firmiert in all other world regions under the name MSD SHARP & DOHME, while Merck KGaA in North America under the name EMD (EM - initials of the firm founder Emanuel Merck; D - Darmstadt) firmiert. The enterprise Merck is considered as the world-wide oldest enterprise of chemistry and Pharmabranche.

While the corporation Merck & Co., Inc. the world-wide third biggest Pharmaunternehmen represents, is Merck KGaA by the majority (approximately 73%) still in family estate, clearly smaller than Merck & Co., Inc.

The emphasis is beside the production of (Nasivin, Toxogonin, Kohlekompretten, Concor with the active substance Bisoprolol, Fortecortin and Metformin), Generika and different offers in the range of the chemical products. Like that Merck KGaA are a pioneer in the range of the LCD technology. Today Merck is the world largest manufacturer of liquid crystals, which are needed for the production of LC/TFT displays (world market portion more than 60%). Further products are pigments for autolacquers and Kosmetika, fine chemicals, chromatography materials and much more besides. With different subsidiaries in different countries Merck KGaA belong to the turnover-strongest Generika manufacturer the world.

Historical

In the year 1668, still in the of the war, the Friedrich Jacob Merck originating from Franconias acquires the angel pharmacy in Darmstadt, which is to become the germ cell of the company.

Beginning 19. Century researches Heinrich Emanuel Merck systematically the pharmaceutical potential of the alkaloids in such a way specified, to a highly effective group of materials, among which among other things morphine ranks. In the year 1827 it begins with production and the selling of these substances in the industriellen yardstick. The alkaloids of the enterprise become rapidly by their purity supraregional admit.

Fast the trade relations grow into all European metropolises. With death Heinrich Emanuels in the year 1855 has the enterprise 50 persons employed. In the year 1887 George Merck transfers the agency of the company to New York, where he 1891 the company Merck & Co. bases.

1903/04 the entire production plants are shifted to the northern edge from Darmstadt, where the enterprise this very day is. Also the production of ready for use medicaments begins at the same time beside the production of raw materials. In the last decade before the First World War rises the conversion of 12 to 26 million Marks.

In consequence of the war effects the enterprise loses the entire foreign business, under it 1917 also the very successful US daughter Merck & Co., by expropriation the USA., which become in the consequence its own American Pharma company.

Into the 1920er the enterprise flowers to years however rapidly. New products, like e.g. Vitamine and plant protection agents, become successful. Among other things also the this very day popular Vitamin C preparation Cebion develops in this time. Up to the year 1929 the conversion of Merck rises to 44 million Marks.

1944 are destroyed the work area of the company to 80%. But soon the reclimb begins nevertheless: Merck grows finally to a global company. Into the 1960er years in the area of liquid crystals one researches intensively, which become soon a third support leg of the business.

Today in 24 countries one produces, for the enterprise are active approximately 29,000 coworkers (of it approx. 9,000 in Germany). For years the enterprise exists the 1990er of at the stock exchange an acted Merck KGaA, which is led by the management. The stock majority of the kg is with the E. Merck OHG, which by the family Merck is still led and which gives strategic guidelines of chemistry and Pharmakonzerns.

To 12. March 2006 confirmed the Schering AG an assumption offer by Merck KGaA. With the success of the assumption a new Pharma large concern with a conversion of over 12 billion euro would have developed. After those delivered Bavarian AG a higher offer, the assumption plans are not further pursued by Merck.

Related links

• Merck KGaA

Articles in category "Merck (enterprise)"

We found here 1 articles.